Published in Am J Pathol on November 01, 2004
Regulation of scar formation by vascular endothelial growth factor. Lab Invest (2008) 1.51
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica (2009) 1.03
Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas. J Physiol (2013) 0.86
Effects of combined radiation and burn injury on the renin-angiotensin system. Wound Repair Regen (2012) 0.85
Absence of venous valves in mice lacking Connexin37. Dev Biol (2012) 0.84
Toxicological and toxicokinetic analysis of angiotensin (1-7) in two species. J Pharm Sci (2011) 0.82
Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction. J Mol Med (Berl) (2014) 0.76
Angiotensin II stimulates melanogenesis via the protein kinase C pathway. Exp Ther Med (2015) 0.75
Angiotensin II inhibitor facilitates epidermal wound regeneration in diabetic mice. Front Physiol (2015) 0.75
Comparison of Hydrogel Produced by Radiation as Applied at the Research Center (Yazd Branch) With MaxGel and Routine Dressing for Second-Degree Burn Repair in Yazd Burn Hospital. Iran Red Crescent Med J (2016) 0.75
Differential effects of Losartan and Atorvastatin in partial and full thickness burn wounds. PLoS One (2017) 0.75
Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro. Stem Cell Res Ther (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
EGF receptor. Int J Biochem Cell Biol (1999) 3.91
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med (2002) 3.74
EGF receptor ligands. Exp Cell Res (2003) 3.60
Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene (2001) 2.66
EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol (2001) 2.46
Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res (1988) 2.20
Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem (1998) 2.10
Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol (2000) 2.05
Rac regulates phosphorylation of the myosin-II heavy chain, actinomyosin disassembly and cell spreading. Nat Cell Biol (1999) 1.87
Angiotensin II receptor antagonists. Lancet (2000) 1.82
Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol (1997) 1.72
Retracted Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res (2001) 1.64
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. J Hypertens (2002) 1.46
A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol (1996) 1.45
A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol (1984) 1.31
Hemidesmosome and desmosome morphogenesis during epidermal wound healing. J Ultrastruct Res (1973) 1.26
Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res (1998) 1.22
Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest (1995) 1.21
Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc Res Tech (1998) 1.17
Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res (2003) 1.15
Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides (1992) 1.11
Retracted Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase. Hypertension (2001) 1.07
Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol (2003) 1.02
Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res (2003) 0.99
Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res (1995) 0.99
Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int Suppl (1997) 0.96
Angiotensin type 2 receptor (AT2R): a challenging twin. Sci STKE (2003) 0.95
Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med (1996) 0.94
Endothelin-1 stimulates human colonic myofibroblast contraction and migration. Gut (2002) 0.94
Acceleration of dermal tissue repair by angiotensin II. Wound Repair Regen (2006) 0.90
Changes in skin angiotensin II receptors in rats during wound healing. Biochem Biophys Res Commun (1992) 0.89
Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept (2000) 0.89
Upregulation of alpha(8)beta(1)-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta1. Am J Physiol Cell Physiol (2001) 0.88
Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen (2001) 0.88
Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices. Biochem Biophys Res Commun (1992) 0.88
Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J Biol Chem (1999) 0.87
Instability of the myofibroblast phenotype in culture. Exp Mol Pathol (1990) 0.87
Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol (2001) 0.86
Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res (2004) 0.86
Alterations of angiotensin II Receptor levels in sutured wounds in rat skin. J Invest Surg (1997) 0.84
Regulation of endothelin-1 production in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol (2001) 0.80
Endogenous EGF-family growth factors are necessary for the progression from the G1 to S phase in human keratinocytes. J Invest Dermatol (1998) 0.79
Risk-benefit assessment of angiotensin II receptor antagonists. Expert Opin Drug Saf (2002) 0.77
Differential expression of activation epitopes of beta1 integrins in psoriasis and normal skin. J Invest Dermatol (1998) 0.77
Hemodynamic and hormonal effects of the angiotensin II antagonist, candesartan cilexetil, in patients with congestive heart failure. Cardiology (2000) 0.77
Comparative inhibitory effects of vitamin D3 and an analogue on normal and psoriatic epidermis in organ culture. Arch Dermatol Res (2000) 0.77
Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. J Dermatol Sci (2006) 1.04
Effect of vessel size and shape on experimental flammability limits of gases. J Hazard Mater (2003) 0.95
Immunohistochemical differentiation of extra-ocular sebaceous carcinoma from other skin cancers. J Dermatol (2004) 0.94
Association of melanogenesis genes with skin color variation among Japanese females. J Dermatol Sci (2012) 0.88
Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis. J Dermatol (2003) 0.86
Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells. Infect Immun (2007) 0.85
Genetic analysis of cutaneous squamous cell carcinomas arising from different areas. Pathol Int (2003) 0.85
Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis. J Agric Food Chem (2010) 0.84
Impaired activation of caspase cascade during cell death induced by newly synthesized singlet oxygen generator, 1-buthylnaphthalene-4-propionate endoperoxide. Cell Biol Int (2008) 0.83
Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection. J Dermatol (2003) 0.83
Variants in melanogenesis-related genes associate with skin cancer risk among Japanese populations. J Dermatol (2014) 0.83
Strongyloides ratti infection in the large intestine of wild rats, Rattus norvegicus. J Parasitol (2005) 0.83
Expression of midkine in normal human skin, dermatitis and neoplasms: association with differentiation of keratinocytes. J Dermatol (2013) 0.81
Hsp40 regulates the amount of keratin proteins via ubiquitin-proteasome pathway in cultured human cells. Int J Mol Med (2011) 0.80
Occurrence and comparison of the expressed keratins in cultured human fibroblasts, endothelial cells and their sarcomas. J Dermatol Sci (2002) 0.80
Therapeutic outcome of hyperbaric oxygen and basic fibroblast growth factor on intractable skin ulcer in legs: preliminary report. Plast Reconstr Surg (2006) 0.79
Eleven novel mutations of the ADAR1 gene in dyschromatosis symmetrica hereditaria. J Dermatol Sci (2012) 0.79
Two children with a mild or moderate piebaldism phenotype and a father without leukoderma in a family with the same recurrent missense mutation in the kinase domain of KIT. Eur J Dermatol (2011) 0.78
Mutation analyses of patients with dyschromatosis symmetrica hereditaria: five novel mutations of the ADAR1 gene. J Dermatol Sci (2010) 0.78
Comparison of keratin expression in cultured human adenocarcinoma cell lines. J Dermatol Sci (2009) 0.78
Four novel mutations of the ADAR1 gene in dyschromatosis symmetrica hereditaria. J Dermatol Sci (2008) 0.77
Dystrophic epidermolysis bullosa pruriginosa of elderly onset. J Dermatol (2010) 0.77
An intractable case of Hermansky-Pudlak syndrome. Intern Med (2014) 0.76
Kuromoji (Lindera umbellata) essential oil-induced apoptosis and differentiation in human leukemia HL-60 cells. Exp Ther Med (2011) 0.76
Positive selection with diversity in oculocutaneous albinisms type 2 gene (OCA2) among Japanese. Pigment Cell Melanoma Res (2014) 0.76
Case of Hermansky-Pudlak syndrome 1 patient with milder symptoms in Japanese. J Dermatol (2014) 0.75
The Hsp90 inhibitor 17-AAG represses calcium-induced cytokeratin 1 and 10 expression in HaCaT keratinocytes. FEBS Open Bio (2012) 0.75
A novel MITF splice site mutation in a family with Waardenburg syndrome. J Dermatol Sci (2008) 0.75
Prurigo pigmentosa on a patient with soft-drink ketosis. J Dermatol (2005) 0.75
Case of a Mongolian child with extensive Mongolian spots in mucopolysaccharidosis type VI: identification of a novel mutation in the arylsulfatase B gene. J Dermatol (2013) 0.75
Oculocutaneous albinism type 3: a Japanese girl with novel mutations in TYRP1 gene. J Dermatol Sci (2011) 0.75
Kuromoji (Lindera umbellata) essential oil inhibits LPS-induced inflammation in RAW 264.7 cells. Biosci Biotechnol Biochem (2013) 0.75
Anti-aging effects of extracts prepared from salmon nasal cartilage in hairless mice. Mol Med Rep (2011) 0.75
Successful treatment of eosinophilic pustular folliculitis with topical tacrolimus. Int J Dermatol (2004) 0.75
Pityriasis rotunda with low levels of steroid sulfatase. Eur J Dermatol (2007) 0.75
Melanotic Malignant Melanoma in Oculocutaneous Albinism Type 4. Acta Derm Venereol (2017) 0.75
Case of oculocutaneous albinism complicated with squamous cell carcinoma, Bowen's disease and actinic keratosis. J Dermatol (2014) 0.75
Glycosylation of tyrosinase is a determinant of melanin production in cultured melanoma cells. Mol Med Rep (2013) 0.75
Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism. Arch Dermatol Res (2008) 0.75
Pediatric case report: clinical profile of a patient with PCWH with p.Q377X nonsense mutation in the SOX10 gene. J Dermatol (2012) 0.75
Topical vitamin D3 is effective in treating senile warts possibly by inducing apoptosis. J Dermatol (2005) 0.75
Burning velocity measurements of nitrogen-containing compounds. J Hazard Mater (2007) 0.75
Anti-aging effects of high molecular weight proteoglycan from salmon nasal cartilage in hairless mice. Int J Mol Med (2012) 0.75
IL36RN gene analysis of two Japanese patients with generalized pustular psoriasis. Int J Dermatol (2015) 0.75
Hermansky-Pudlak syndrome type 4 with a novel mutation. J Dermatol (2014) 0.75
Flammability assessment of CH2CFCF3: comparison with fluoroalkenes and fluoroalkanes. J Hazard Mater (2009) 0.75
Dyschromatosis symmetrica hereditaria: a case report from Turkey, a new association and a novel gene mutation. J Dermatol (2012) 0.75